Insider trade

Insight Molecular Diagnostics (IMDX)10% owner bought ~$9.24M

BROADWOOD PARTNERS, 10% owner at Insight Molecular Diagnostics, bought ~$9.24M of Insight Molecular Diagnostics shares.

~$9.24M
Approx. value · 4.51M sh @ $2.05: 11.4M
Holds after · shares reported

Traded: Feb 6, 2025
Filed: Feb 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Dec 5, 2024InsiderCFO purchased ~$46K of OCX shares in the open market
Dec 26, 2024Insider · 2 peopleInsiders: 2 purchases (~$219K)
Jan 13, 2025Insider10% owner purchased ~$12K of OCX shares in the open market
Jan 14, 2025Insider · 1 personInsiders: 2 purchases (~$22K)
Jan 29, 2025Insider10% owner purchased ~$7.8K of OCX shares in the open market
Jan 30, 2025Insider10% owner purchased ~$639 of OCX shares in the open market
Jan 31, 2025Insider10% owner purchased ~$1.8K of OCX shares in the open market
Feb 4, 2025Insider10% owner purchased ~$51 of OCX shares in the open market
Feb 6, 2025 · this disclosureInsider10% owner purchased ~$9.24M of OCX shares in the open market

What came next

Feb 6, 2025Insider10% owner purchased ~$1.35M of OCX shares in the open market
Feb 7, 2025Insider · 2 peopleInsiders: 2 purchases (~$2.4M)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Insight Molecular Diagnostics

OQRO holds no insider, Congress, fund or contract record for Insight Molecular Diagnostics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMDX page.

Other recent filings by BROADWOOD PARTNERS, L.P., 10% owner

The full history of BROADWOOD PARTNERS, L.P., 10% owner is on the profile page.

How this filing works

Other disclosures at Insight Molecular Diagnostics

Everything OQRO holds on this company is on its IMDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data